Christine Esposito, Managing Editor05.19.21
Throughout the COVID-19 pandemic, Cleveland Clinic and The Clorox Company have collaborated on health and safety measures to limit the spread of the virus in everyday life and in the workplace. Now, the two organizations are taking this commitment a step further by establishing the Clorox Public Health Research Fund. Bolstered by a $1 million donation from Clorox, the fund will further Cleveland Clinic’s exploration of innovative research ideas, advance new training and education opportunities, and launch promising healthcare innovations.
The goals of the Clorox Public Health Research Fund include initiating promising health technology, investigating new research approaches, and designing healthcare solutions. Initially, the organizations will prioritize research and discovery focused on the COVID-19 virus.
Research supported by the fund will inform the development of tomorrow’s virus-fighting cleaners and other health and safety products, along with practices and protocols.
“Research to better understand this pandemic is vitally important and where immediate funding makes a critical difference,” said Serpil Erzurum, M.D., chief research and academic officer at Cleveland Clinic. “Funds from Clorox will allow us to accomplish more and have a broader, meaningful impact on discovery and innovations for COVID-19 and for many other future public health threats.”
“As a health and wellness company, we are proud to be extending our work with Cleveland Clinic in support of public health,” said Ed Huber, vice president of strategic growth and chief sustainability officer at The Clorox Company. “It’s important that we continue to advance research and develop science-based innovations with Cleveland Clinic to help fight COVID-19, and to help us be better prepared in the future.”
The goals of the Clorox Public Health Research Fund include initiating promising health technology, investigating new research approaches, and designing healthcare solutions. Initially, the organizations will prioritize research and discovery focused on the COVID-19 virus.
Research supported by the fund will inform the development of tomorrow’s virus-fighting cleaners and other health and safety products, along with practices and protocols.
“Research to better understand this pandemic is vitally important and where immediate funding makes a critical difference,” said Serpil Erzurum, M.D., chief research and academic officer at Cleveland Clinic. “Funds from Clorox will allow us to accomplish more and have a broader, meaningful impact on discovery and innovations for COVID-19 and for many other future public health threats.”
“As a health and wellness company, we are proud to be extending our work with Cleveland Clinic in support of public health,” said Ed Huber, vice president of strategic growth and chief sustainability officer at The Clorox Company. “It’s important that we continue to advance research and develop science-based innovations with Cleveland Clinic to help fight COVID-19, and to help us be better prepared in the future.”